Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

UNKNOWN × Thymoma × Clear all

Phase

Status

Sponsor Class

OTHER 64 INDUSTRY 17 NIH 13 NETWORK 4 OTHER_GOV 2 UNKNOWN 1

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 36 Esophageal Neoplasms 21 Stomach Neoplasms 18 Carcinoma, Non-Small-Cell Lung 13 Rectal Neoplasms 12 Colorectal Neoplasms 11 Triple Negative Breast Neoplasms 9 Small Cell Lung Carcinoma 8 Squamous Cell Carcinoma of Head and Neck 7 Neoplasms 7 Lung Neoplasms 7 Brain Neoplasms 7 Esophageal Squamous Cell Carcinoma 6 Neoplasm Metastasis 5 Carcinoma, Hepatocellular 5 Recurrence 4 Radiation Injuries 4 Nasopharyngeal Carcinoma 4 Lymphoma, Large B-Cell, Diffuse 4 Lymphoma, Extranodal NK-T-Cell 4 Head and Neck Neoplasms 4 Melanoma 3 Lymphoma 3 Leukemia, Myeloid, Acute 3 HER2-positive Breast Cancer 3 Colonic Neoplasms 3 Vomiting 2 Uterine Cervical Neoplasms 2 Skin Neoplasms 2 Skin Diseases 2

Interventions

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02014805 2020-07-16

Postoperative Conformal Radiotherapy for Stage II-III B Type Thymoma

ChineseAMS

Phase 3 Unknown

Thymoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡